SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001654954-21-010885
Filing Date
2021-10-07
Accepted
2021-10-07 14:40:16
Documents
1
Period of Report
2020-11-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT section16.html 3  
1 PRIMARY DOCUMENT section16.xml 3 1312
  Complete submission text file 0001654954-21-010885.txt   2968
Mailing Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212
Business Address 9350 WILSHIRE BLVD. SUITE 203 BEVERLY HILLS CA 90212 (800) 304-9888
GT Biopharma, Inc. (Issuer) CIK: 0000109657 (see all company filings)

IRS No.: 941620407 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 70 ELEVEN O'CLOCK ROAD WESTON CT 06883
Business Address
Wendel Bruce (Reporting) CIK: 0001364846 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40023 | Film No.: 211312176